Read + Share
Amedeo Smart
Independent Medical Education
Hu Y, Byrne KS, Bidel Z, Xiao X, et al. Antihypertensive Treatment and Risk of Metabolic Associated Fatty Liver Disease: A Drug-Target Mendelian Randomization. Hypertension 2026 Sep 18. doi: 10.1161/HYPERTENSIONAHA.126.27526.PMID: 42755691
Email
LinkedIn
Privacy Policy